Summary. Extracellular Ca 2+, at concentrations exceeding 10 mmol/1, causes a dose-related stimulation of insulin release. The dynamics of Ca2+-induced insulin release are characterized by a quick onset, a progressive build-up and a later return towards basal secretory rate. The release of insulin evoked by Ca 2+ is inhibited in the presence of either Mg 2+ (10 mmol/1) or the organic Ca2+-antagonist verapamil (81 ~tmol/1), both of which are known to inhibit Ca 2+ entry in the B-cell. Glucose and theophylline, which are thought to affect the net uptake or intracellular distribution of Ca 2+ in the B-cell, both enhance Ca2+-induced insulin release. As little as 2.7 mmol/l glucose is sufficient to augment Ca 2+-induced insulin secretion. Exposure of the pancreas to somatostatin significantly retards the secretory response to Ca 2+. Cytochalasin B potentiates the insulin release evoked by Ca 2+ (12 mmol/1) and lowers the threshold concentration of Ca 2+ required to stimulate secretion. These data suggest that high extracellular Ca 2+ concentrations may sufficiently increase the amount of Ca 2+ accumulated in the B-cell to eventually trigger insulin release. Agents known to cause a remodelling of Ca 2+ fluxes across membrane systems in the B-cell interfere with Ca 2+-induced insulin release, a process also dependent on the integrity of the cytochalasin B-sensitive microfilamentous effector system.
Intracellular Ca 2+ plays an essential role in the process of insulin release [1] . It is generally considered that Ca z+ acts as a trigger for the machinery controlling the exocytosis of secretory granules, whatever agent is used to stimulate insulin release [2] . This concept is supported by the recent finding that Ca 2+ itself is able to promote insulin release [3, 4] . The secretory response evoked by high extracellular Ca 2+ concentrations is influenced by agents known to inferfere with Ca 2+ fluxes into or within the B-cell, such as verapamil, L-epinephrine and methylxanthines [3, 4] .
The present experiments were designed to characterize the dynamics and mechanism of Ca2+-induced insulin release.
Material and Methods
Pancreases were removed from fully fed, male albino rats (approximately 250-300 g body weight) and placed in an open circuit extracorporeal perfusion unit, as described in detail elsewhere [5] . The perfusate consisted of a Hepes buffer (25 mmol/l; pH 7.4) with the following ionic composition: Na + 130, K + 5, Mg 2+ 1 and C1-122 mmol/l. The use of a Hepes-as distinct from bicarbonate-buffered medium allowed the use of Ca 2+ in high concentrations without causing precipitation of Ca 2+ salts. In view of the results reported by Hellmann [4] , no compensation for the changes in osmotic pressure were made, the osmolarity varying between 313 (Ca 2+ 10 mmol/1) and 337 (Ca 2+ 18 mmol/l) mosmol/1. The perfusate also contained albumin (5 mg/ml; Fraction V; Sigma Chemicals Co., St. Louis, Mo), dextran (40 mg/ml; T70; Pharmacia Fine Chemicals, Uppsala, Sweden) and as required glucose, theophylline, verapamil (Knoll A.G., Ludwigshafen, Germany) somatostatin (G.I.F.; linear synthetic lyophilized; I.F. Serono, Rome, Italy) and cytochalasin B (Aldrich Chemical Co., Milwaukee, Wisconsin), which was dissolved in dimethylsulphoxide (final concentration of the solvent: 0.1%, 1//I1). The immunoassay method for insulin is detailed elsewhere [5] . The rates of insulin secretion are expressed as ~tU/min per pancreas. 
Dose-Action Relationship for Ca2+-Induced Insulin Release
After perfusion for 25 minutes with a solution free of Ca 2+, the pancreases were exposed to increasing concentrations of extracellular Ca 2+ (Fig. 1) . The threshold concentration for the stimulatory action of Ca 2+ lay between 10 and 12 retool/1. The dose-action relationship for Ca2+-induced insulin release is illustrated in the upper part of Figure 1 , which refers to the integrated output of insulin over 16 minutes exposure to various Ca 2+ concentrations.
Pattern of Ca2+-Induced Insulin Release
At the highest extracellular Ca 2 § concentrations, the increase in insulin output was detectable within 1-2 minutes of exposure to Ca 2+. However, the maximal rate of secretion was not reached until the 10th-16th minutes after the introduction of Ca 2+ (Fig. 1) . Such a maximal secretory rate represents at least twice that evoked by glucose (16.7 mmol/1) at close to physiological Ca 2+ concentration (2 mmol/l). The progressive build-up in secretory rate during the initial period of exposure to Ca 2+ was soon followed by a progressive decline in insulin output (Fig. 2) . Eventually the rate of secretion returned to its basal value, which was reached after approximately 35-40 minutes of exposure to Ca z+. The fall in secretory rate during the late period does not imply a total lack of responsiveness of the pancreas, since the addition of glucose (16.7 mmol/1) at the 20th minute of exposure to Ca 2+ was still able to enhance the output of insulin (see inset of Figure 2 ).
Inhibition of Ca2+-Induced Insulin Release
When Mg z+ (10 mmol/1) was present from the beginning of the perfusion, a complete inhibition of Ca2+-evoked insulin release was observed ( Fig. 3 and Table 1 ). The organic Ca2+-antagonist verapamil, which inhibits Ca 2+ influx in the pancreatic B-cell [6] , also caused inhibition of Ca2+-induced insulin secretion at a concentration of 81 gmol/1 ( Table 1) . Exposure of the pancreas to somatostatin (1.25 pg/ml) from time 0 to the 35th minute significantly retarded the Ca2+-evoked insulin release (Fig. 4) . From the 25th to 35th minute of perfusion the integrated insulin output in the presence of somatostatin averaged 48 _+ 8% (P < 0.02) of the mean control value found in its absence.
Potentiation of Ca2+-Induced Insulin Release
When administered together with Ca 2+, glucose (16.7 mmol/1) caused a dramatic increase in the output of insulin observed at the lowest active concentration of Ca 2+ (12 mmol/1). Under these experimental conditions an apparently biphasic insulin response was observed. Glucose, at a concentration Of 2.7 mmol/1, failed to affect insulin release at normal (Fig. 6 ), but failed to affect significantly the higher rate of secretion evoked by Ca z+ 18 retool/1 (Table 1) . Cytochalasin B apparently lowered the threshold value for the stimulatory action of Ca 2+ on insulin release. Indeed, in the presence of cytochalasin B, a Ca 2+ concentration of 10 mmol/l was sufficient to increase insulin output significantly. The total amount of insulin released over the 16 minute period of exposure to Ca 2 § 10 mmol/1 averaged 560 _+ 164 ~tU (n = 5) and 1 474 _+ 320 FU (n = 5) in the absence and presence of cytochalasin B, respectively.
Discussion
We have recently shown that, in the absence of any other secretagogue, Ca 2+ is able to provoke a shortlived insulin response in the perfused rat pancreas first exposed to the Ca2+-chelating agent (EGTA [3] . Hellman, using a Hepes-buffered medium, was able to provide even more direct evidence for the stimulatory role of Ca z+, showing that under suitable experimental conditions pretreatment with a Ca2+-deficient medium is not a pre-requisite for the divalent cation to induce insulin release [4] . The data presented in this report confirm that extracellular Ca z+ concentrations, above a threshold value of 10 mmol/1, provoke a dose-dependent stimula-tion of insulin secretion. In contrast with the brief spike of insulin release obtained after pretreatment with EGTA [3] , a progressive build-up and monophasic insulin response was observed. The reason why a sustained secretion of insulin failed to occur is not evident. It could be due to an untoward metabolic effect, since after prolonged exposure (90 rain) to a high Ca 2+ concentration (20 mmol/1), glucose fails to exert its usual stimulant action on 45Ca2+ net uptake by isolated islets (unpublished observations). The assumption that an increase in the size of the functionally active pool(s) of Ca 2+ above a certain optimal value could induce per sea diminished insulin secretory response seems untenable [8] . Indeed, glucose, which is known to cause an increase in the total net uptake of Ca 2+ by the B-cell, remained capable of enhancing insulin output at the very time during perfusion when the hormonal release was falling towards its basal level.
The insulinotrophic effect of Ca 2+ could be due to the fact that high extracellular Ca 2+ concentrations favour the cytosolic accumulation of this cation, ultimately triggering the secretory response. Unpublished observations have shown that, over 90 minutes incubation in the absence of glucose, the net uptake of 45Ca 2+ by isolated islets dramatically increases, from 1.34 + 0.10 to 9.52 + 0.74 pmol/ islet (n = 13 in each case), as the Ca 2+ concentration of the Hepes-buffered incubation medium is raised from 5 to 20 mmol/1.
It is likely that, in the process of Ca2+-induced insulin release, the rate of Ca 2+ entry in the B-cell plays a critical role. The latter hypothesis is supported by the finding that CaZ+-induced insulin release is inhibited at high extracellular Mg 2+ concentrations. We have previously shown that Mg 2+ is a potent inhibitor of Ca 2+ entry in the B-cell [9] , probably by competing with Ca 2+ for a common cationic carrier-system located within the B-cell plasma membrane. The same competitive effect of Mg 2+ is observed in the case of Ba 2+ uptake by the B-cell [10] . The organic Ca2+-antagonist verapamil also inhibits Ca2+-induced insulin release. It is thus plausible that under the present experimental conditions, Ca 2+ enters the B-cell at the intervention of a native ionophoretic system which, like the exogenous ionophore A23187, would act by virtue of its verapamilsensitive Ca2+-binding sites [7] . We have indeed recently observed that verapamil inhibits the capacity of the ionophore A23187 to provoke Ca 2+ translocation in an artificial model [11] . Verapamil could also interfere with the Ca2+-binding sites of the native ionophoretic systems located in the B-cell plasma membrane and, by doing so, inhibit the entry of Ca 2+ in the B-cell.
It has been proposed by various investigators that the effects of somatostatin on hormonal discharge are related to an alteration in the handling of or response to Ca 2+ [12] [13] [14] . This hypothesis is compatible with the wide-spread inhibitory action of somatoStatin on hormone release [15] [16] [17] [18] [19] [20] [21] and the role of Ca 2+ as a cellular messenger in various secretory cells [22] . The data here" obtained with somatostatin are also in good agreement with such a hypothesis. Exposure of the pancreas to somatostatin did significantly retard the secretory response to Ca 2+. It was recently shown that somatostatin (2 ~tg/ml) significantly decreases glucose-induced 45Ca2+-uptake by isolated islets [14] .
The potentiating effect of glucose upon Ca2+-induced insulin release is consistent with the fact that this hexose increases the net uptake of Ca 2+ by the B-cell. Our finding that a 2.7 mmol/1 concentration of glucose was sufficient to enhance Ca2+-induced insulin release would suggest that this sugar is able to affect Ca2+-handling even when used at a concentration far below that normally required to stimulate insulin release. This is not surprising since the rate of glycolysis, which exerts a tight control upon Ca 2+ net uptake by the B-cell [23] , is indeed higher in the presence of glucose 2.7 retool/1 than in the absence of glucose. Moreover, the efflux of 45Ca2+ from perifused islets is slightly but significantly reduced by glucose in a concentration (2.5 mmol/1) lower than that required to stimulate insulin release at a physiological concentration of extracellular Ca 2 § [24] .
Theophylline also enhanced Ca2+-evoked insulin release, a finding which is in good agreement with the data obtained by Hellman with isobutylmethylxanthine [4] . These phosphodiesterase inhibitors augment the cyclic-AMP content of the B-cell [8, 25] and, by doing so, may cause a redistribution of Ca 2 § ions within the B-cell [26] . Since cyclic-AMP is known to inhibit the net uptake of Ca 2+ by B-cell subcellular particulate fractions [27] , our findings suggest that the ability of mitochondria and/or other organelles to store divalent cations plays an important counter-regulatory role in modulating the magnitude of the secretory responses to either Ca 2+ or Ba 2+ [10] .
Taken as a whole, the present data are compatible with the idea that a rise in the extracellular Ca 2+ concentration, by increasing Ca 2+ entry and/or inhibiting Ca 2+ efflux, provokes a sufficient accumulation of Ca 2+ in the B-cell to stimulate insulin release. It has been proposed that the cytosolic accumulation of Ca 2+ triggers insulin secretion by activating a microtubular-microfilamentous effectorsystem responsible for the exocytosis of secretory granules. Our findings with cytochalasin B reinforce this concept, since CaZ+-induced insulin release is itself enhanced by this metabolite. As already reported in the case of glucose-or leucine-induced insulin secretion [5, 28] , cytochalasin B not only potentiates the secretory response to the secretagogues but also lowers the threshold concentration at which insulinotropic agents become able to evoke insulin release. The mould metabolite may thus sensitize the response of the effector system to sub-threshold concentrations of cytosolic Ca 2+ [29] .
